SUSQUEHANNA INTERNATIONAL GROUP, LLP - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 59 filers reported holding EIDOS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$16,728,000
+355.2%
127,120
+74.8%
0.00%
+100.0%
Q3 2020$3,675,000
+21.1%
72,722
+14.3%
0.00%
Q2 2020$3,034,000
-55.2%
63,649
-54.0%
0.00%
-100.0%
Q1 2020$6,777,000
-48.6%
138,334
-39.8%
0.00%
-50.0%
Q4 2019$13,194,000
+1495.4%
229,900
+899.4%
0.00%
Q3 2019$827,000
+606.8%
23,003
+95.5%
0.00%
Q3 2018$117,00011,7640.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders